Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHYDG.L Regulatory News (HYDG)

  • There is currently no data for HYDG

Director/PDMR Shareholding

6 Jun 2017 07:00

RNS Number : 2059H
Hydrogen Group PLC
06 June 2017
 

Hydrogen Group Plc

("Hydrogen" or the "Company")

Grant of options and Director/PDMR shareholding

Hydrogen Group Plc (AIM: HYDG), a global specialist recruitment business, announces that 1.66 million options have been granted to certain directors and PDMRs at an exercise price at 34 pence in relation to its Leadership Share Scheme. The terms and split of the options is as follows:

 

Director/PDMR

Date of grant

Number of options

Ian Temple

01/06/2017

500,000

John Hunter

02/06/2017

500,000

Lee Chant

01/06/2017

330,000

Amber Hayat

01/06/2017

330,000

 

The options vest in four tranches over a period spanning from May 2018 to May 2021 and have performance criteria relating to earning per share with a target range of 4.05p to 13.67p dependant on the vesting date. The options expire on 2 June 2027.

Ian Temple and John Hunter are currently interested in 4,048,726 and 1,646,872 ordinary shares respectively, Ian Temple also has options over 24,000 ordinary shares. Lee Chant and Amber Hayat, prior to the above grant, currently hold options over 330,000 and 100,000 ordinary shares respectively.

For further information please contact:

 

Hydrogen Group plc

Ian Temple, CEO

 

 

 

Tel: 020 7090 1630

 

Shore Capital (Nomad and Broker)

Bidhi Bhoma, Edward Mansfield and James Wolfe

 

Tel: 020 7408 4090

For more information, visit www.hydrogengroup.com 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLFFILRVIEIID
Date   Source Headline
19th May 20205:26 pmRNSNotice of AGM
7th Apr 20207:00 amRNSFinal results for year ended 31 December 2019
27th Feb 20202:05 pmRNSSecond Price Monitoring Extn
27th Feb 20202:00 pmRNSPrice Monitoring Extension
16th Jan 20207:00 amRNSTrading Update
15th Nov 201912:19 pmRNSTrading Statement
18th Sep 20195:29 pmRNSDealing in Company shares
9th Sep 20196:01 pmRNSDealing in Company shares
4th Sep 20195:30 pmRNSDealing in Company shares
4th Sep 20195:26 pmRNSHolding(s) in Company
3rd Sep 20197:43 amRNSInterim Results
29th Aug 20197:00 amRNSInterim Results Date
15th Jul 20197:00 amRNSTrading Statement and Notice of Results
24th May 20198:43 amRNSResult of AGM
23rd May 20197:00 amRNSAGM Statement
22nd May 20193:49 pmRNSIssue of Equity
29th Apr 20197:00 amRNSNotice of AGM
25th Apr 20192:32 pmRNSIssue of Equity
12th Apr 20194:32 pmRNSHolding(s) in Company
2nd Apr 20197:00 amRNSFinal Results
12th Mar 20197:00 amRNSMaterial Contract Renewal with FTSE100 Retail Bank
25th Jan 20197:00 amRNSTrading Statement
17th Dec 20186:08 pmRNSDealing in Company shares
26th Nov 20187:00 amRNSDealing in Company shares
6th Nov 20187:00 amRNSTrading Statement
1st Nov 20187:00 amRNSIssue of Equity
31st Oct 20187:00 amRNSDealing in Company shares
30th Oct 20187:00 amRNSDealing in Company shares
17th Oct 20184:00 pmRNSDigital Marketing Recognition
10th Oct 20187:00 amRNSUS Office Expansion
19th Sep 20184:21 pmRNSInterim Dividend Timetable
18th Sep 20187:00 amRNSHalf-year Report
15th Aug 201812:52 pmRNSHolding(s) in Company
10th Aug 20181:57 pmRNSReplacement: Issue of Equity
7th Aug 20182:46 pmRNSIssue of Equity
17th Jul 20187:00 amRNSTrading Update and Notice of Interim Results
3rd Jul 20187:00 amRNSNotice of trading update
29th Jun 20183:15 pmRNSIssue of Equity and Director Dealing
1st Jun 20183:38 pmRNSTotal Voting Rights
1st Jun 20182:03 pmRNSHolding(s) in Company
31st May 20184:48 pmRNSDirector/PDMR Shareholding
31st May 201812:10 pmRNSIssue of Equity, Director / PDMR holding
25th May 201812:09 pmRNSResult of AGM
25th May 20187:00 amRNSAGM Statement
16th Apr 20183:32 pmRNSHolding(s) in Company
10th Apr 20187:00 amRNSFinal Results
3rd Apr 20187:00 amRNSTotal Voting Rights
26th Mar 20187:00 amRNSNotice of Results
11th Jan 20187:00 amRNSBlock listing Interim Review - Unapproved
11th Jan 20187:00 amRNSBlock listing Interim Review - EMI

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.